Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Spectral AI ( (MDAI) ) has provided an update.
On April 17, 2026, Spectral AI’s board approved an employment agreement formalizing Vincent S. Capone’s role as Chief Executive Officer, reflecting his start date of February 9, 2026 and earlier appointment announced in February. The package includes a $500,000 annual base salary, an annual performance-based bonus opportunity of up to 100% of salary with a $250,000 minimum, continued 401(k) contributions, standard employee benefits, and participation in a forthcoming executive exit bonus plan tied to a future sale of the company.
Capone was granted 200,000 restricted stock units under the company’s long‑term incentive plan, with 50% vesting on April 1, 2026 and the remainder on April 1, 2027, and all equity vesting upon a change of control. The agreement maintains his at‑will employment status but provides for 12 months of salary continuation, extended benefits, and accelerated vesting of equity if he is terminated without cause or resigns for good reason, underscoring Spectral AI’s effort to secure and align its top leadership during a period that could include strategic transactions.
The most recent analyst rating on (MDAI) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on Spectral AI stock, see the MDAI Stock Forecast page.
Spark’s Take on MDAI Stock
According to Spark, TipRanks’ AI Analyst, MDAI is a Neutral.
The score is held back primarily by weak financial performance (losses, negative equity, and ongoing cash burn). This is partially offset by a positive earnings-call outlook driven by BARDA funding and regulatory progress, and supported by improving near-term technical momentum; valuation remains unfavorable due to continuing losses and no dividend.
To see Spark’s full report on MDAI stock, click here.
More about Spectral AI
Spectral AI, Inc., through its operating subsidiary Spectral MD, Inc., operates in the medical technology sector and focuses on advanced imaging and AI-driven diagnostic solutions for wound care. The company targets clinical and hospital settings, positioning its leadership team and incentive structures to support growth, strategic transactions and long-term shareholder value.
The business emphasizes executive participation in equity-based compensation and benefit plans as it pursues operational and potential M&A objectives within its segment of the healthcare market.
Average Trading Volume: 669,850
Technical Sentiment Signal: Buy
Current Market Cap: $60.15M
Learn more about MDAI stock on TipRanks’ Stock Analysis page.